Susilo Wagino MulyoGlucagon-like peptide-1 receptor agonists (GLP-1s), a class of medications originally developed for type 2 diabetes, have gained significant attention for their efficacy in weight management, which in turn holds promise…
Hanik KholidahIn a landmark decision that marks one of the most significant shifts in women’s healthcare in decades, the medical community has officially moved to rename Polycystic Ovary Syndrome (PCOS) to…
Susilo Wagino MulyoThe landscape of treating obstructive sleep apnea (OSA), a pervasive condition affecting millions, is undergoing a significant transformation with the advent and increasing adoption of glucagon-like peptide-1 receptor agonists (GLP-1s).…
Hanik KholidahThe transition from active cancer treatment to the status of "cancer-free" is frequently characterized in public discourse as a definitive finish line, yet for actress Miranda McKeon, the reality of…
Susilo Wagino MulyoThe landscape of sleep apnea treatment is undergoing a significant transformation with the emergence of Glucagon-like peptide-1 receptor agonists (GLP-1s), a class of medications initially developed for type 2 diabetes…
Hanik KholidahIn a significant leap forward for the field of synthetic biology and precision medicine, researchers at Texas A&M University have unveiled a groundbreaking method to control gene-editing tools and therapeutic…
Susilo Wagino MulyoThe emergence of Glucagon-like peptide-1 (GLP-1) receptor agonists, initially heralded for their efficacy in managing type 2 diabetes, has dramatically reshaped discussions around weight loss and, more recently, the treatment…
Susilo Wagino MulyoThe emergence of Glucagon-like peptide-1 receptor agonists (GLP-1s), such as Ozempic, Wegovy, and Zepbound, has introduced a new paradigm in the management of chronic conditions, particularly type 2 diabetes and…
Hanik KholidahIn a landmark development for cardiovascular and neurological medicine, the newly released C-CHANGE/CMAJ 2026 clinical guidelines have officially recognized the bidirectional relationship between the human heart and the brain. This…
Susilo Wagino MulyoThe landscape of sleep apnea treatment is undergoing a significant evolution with the emergence of Glucagon-like Peptide-1 (GLP-1) receptor agonists, a class of medications initially developed for type 2 diabetes…
